APOE and Alzheimer disease: Similarly, data from the BioFINDER study showed that plasma p-tau181 could accurately predict the development of AD within six years among cognitively unimpaired individuals, with predictive accuracy that was further improved when combined with p-tau217 and the APOE genotype [88].